Therapy Areas: Respiratory
GSK secures China approval for Exdensur to treat nasal polyp condition
8 April 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) revealed on Wednesday that it has received approval from China's National Medical Products Administration for Exdensur (dep...
Dexcel Pharma's Nintedanib Capsules approved for US launch
8 April 2026 - Dexcel Pharma USA, a subsidiary of Israeli pharmaceutical company Dexcel Pharma, announced on Tuesday that it has received final approval from the US Food and Drug Administration (FDA) ...
Gilead to acquire Tubulis to expand ADC oncology capabilities
7 April 2026 - US biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) announced on Tuesday that it has entered into a definitive agreement to acquire Tubulis GmbH, a German clinical-stage biot...
Sanofi reports positive phase 2 results for lunsekimig in asthma and CRSwNP
7 April 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) reported on Tuesday that its investigational candidate lunsekimig met primary and key secondary endpoints in phas...
Akeso reports updated data on cadonilimab combination therapy in PD-(L)1 inhibitor-resistant advanced NSCLC data
7 April 2026 - Chinese biopharmaceutical company Akeso Inc (HK:9926) said on Monday that, at the 2026 European Lung Cancer Congress (ELCC 2026), it reported updated results with a median follow-up of ...
Parnell launches first FDA-approved generic florfenicol and flunixin combination for bovine respiratory disease
1 April 2026 - Veterinary pharmaceutical company Parnell Technologies Pty Ltd on Wednesday announced the US launch of nixiFLOR, an injectable solution approved by the US Food and Drug Administration (...